Intensified Chemotherapy With ACVBP Plus Rituximab Versus Standard CHOP Plus Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (LNH03-2B): An Open-Label Randomised Phase 3 Trial
Rituximab